Novel Synthesis of Cholesterol

AI-generated visualisation of the inventionAI
Publication: EP4089100A1
Published: 2022-11-16
Family Size: 12
Granted: No

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent discloses a novel chemical method for synthesizing cholesterol from plant-derived diosgenin instead of traditional animal sources. The process involves protecting specific groups on diosgenin, opening certain rings in its structure, activating and reducing intermediates, and ultimately producing pure cholesterol. The method improves upon existing technologies by using renewable plant materials and producing less waste.

Use CasesContent extracted from patent full text and abstract with AI.

  • Industrial-scale production of cholesterol for pharmaceuticals, cosmetics, and food supplementation.
  • Synthesis of steroid hormones and vitamin D precursors for medical and research applications.
  • Manufacture of cholesterol-containing drug delivery systems, such as lipid nanoparticles for vaccines.
  • Reduction of dependency on animal-derived cholesterol in various industries, increasing vegan/vegetarian-compatible products.
  • Production of cholesterol in regions with restrictions on animal-derived products or concerns about animal-borne contaminants.

BenefitsContent extracted from patent full text and abstract with AI.

  • Provides a sustainable and ethical alternative to animal-sourced cholesterol, reducing reliance on livestock and minimizing environmental impact.
  • Reduces risk of contamination by animal-borne pathogens such as prions.
  • Produces cholesterol with high purity and yield, improving process efficiency and lowering manufacturing costs.
  • Generates less industrial waste compared to traditional extraction methods from animal tissues.
  • Enables consistent and scalable cholesterol production independent of animal agriculture and global livestock supply fluctuations.

Technical Classifications (CPCs)

Main Classifications

Chemistry & Materials Science

Sub Classifications

Organic Chemistry

CPC Codes

C07J9/00C07J31/006C07J41/0055C07J71/0005C07J75/00

Inventors & Applicants

Applicants

Cordenpharma Int Gmbh

Univ Otto von Guericke Magdeburg

Patent Abstract

The invention relates to a synthesis of cholesterol; a ring opening step of the compound of formula (I)and subsequent activation and reduction step yielding cholesterol. The inventions relates also to intermediates achieved during said synthesis.

Key Information

Publication No.

EP4089100A1

Family ID

75936712

Publication Date

2022-11-16

Application No.

EP21173824A

Application Date

2021-05-14

Priority Date

2021-05-14

Granted

No

Possible Cooperation

For further information please contact the transfer office.